| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A (Latent) Class of Their Own: Response Patterns in Trading Off Quantity and Quality of Life in Time Trade-Off Exercises
|
van Nooten, F.E.
|
|
2017
|
20 |
10 |
p. 1403-1410
|
article
|
| 2 |
An Exploratory Study on Using Principal-Component Analysis and Confirmatory Factor Analysis to Identify Bolt-On Dimensions: The EQ-5D Case Study
|
Finch, Aureliano Paolo
|
|
2017
|
20 |
10 |
p. 1362-1375
|
article
|
| 3 |
Author Response: Patient Engagement
|
Frank, Lori
|
|
2017
|
20 |
10 |
p. 1433
|
article
|
| 4 |
Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Cost-Utility Analysis
|
Dawoud, Dalia
|
|
2017
|
20 |
10 |
p. 1279-1287
|
article
|
| 5 |
Comparing Methods for Estimating Direct Costs of Adverse Drug Events
|
Gyllensten, Hanna
|
|
2017
|
20 |
10 |
p. 1299-1310
|
article
|
| 6 |
Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Multicriteria Decision Analysis
|
Tervonen, Tommi
|
|
2017
|
20 |
10 |
p. 1394-1402
|
article
|
| 7 |
Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions: An Illustration for Metastatic Castration-Resistant Prostate Cancer
|
Degeling, Koen
|
|
2017
|
20 |
10 |
p. 1411-1419
|
article
|
| 8 |
Copyright/Subscription
|
|
|
2017
|
20 |
10 |
p. iv
|
article
|
| 9 |
Cost Effectiveness of Candida Polymerase Chain Reaction Detection and Empirical Antifungal Treatment among Patients with Suspected Fungal Peritonitis in the Intensive Care Unit
|
Pagès, Arnaud
|
|
2017
|
20 |
10 |
p. 1319-1328
|
article
|
| 10 |
Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands: A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines
|
Ramos, Isaac Corro
|
|
2017
|
20 |
10 |
p. 1260-1269
|
article
|
| 11 |
Development and Validation of the AFImpact: An Atrial Fibrillation–Specific Measure of Patient-Reported Health-Related Quality of Life
|
Coyne, Karin S.
|
|
2017
|
20 |
10 |
p. 1355-1361
|
article
|
| 12 |
Editorial Board
|
|
|
2017
|
20 |
10 |
p. IFC
|
article
|
| 13 |
Effect of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure: A Network Meta-Analysis
|
Guo, Wen-Qin
|
|
2017
|
20 |
10 |
p. 1427-1430
|
article
|
| 14 |
Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer
|
Adams, Alyce S.
|
|
2017
|
20 |
10 |
p. 1345-1354
|
article
|
| 15 |
Forecasting the Long-Term Clinical and Economic Outcomes of Lumacaftor/Ivacaftor in Cystic Fibrosis Patients with Homozygous phe508del Mutation
|
Dilokthornsakul, Piyameth
|
|
2017
|
20 |
10 |
p. 1329-1335
|
article
|
| 16 |
Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial: An Update with Empirical Trial–Based Cost Data
|
Laxy, Michael
|
|
2017
|
20 |
10 |
p. 1288-1298
|
article
|
| 17 |
ISPOR Code of Ethics 2017 (4th Edition)
|
Santos, Jessica
|
|
2017
|
20 |
10 |
p. 1227-1242
|
article
|
| 18 |
Letter to the Editor: Emerging Guidelines for Patient Engagement in Research
|
Boutin, Marc
|
|
2017
|
20 |
10 |
p. 1431-1432
|
article
|
| 19 |
Nephrectomy Complication Is a Risk Factor of Clinically Meaningful Decrease in Health Utility among Living Kidney Donors
|
Hosseini, Kossar
|
|
2017
|
20 |
10 |
p. 1376-1382
|
article
|
| 20 |
Next Edition of the ISPOR Code of Ethics: Is It Setting Us up for the Era of Digitized Health Care?
|
|
|
2017
|
20 |
10 |
p. 1243-1244
|
article
|
| 21 |
Patient Preferences for Device-Aided Treatments Indicated for Advanced Parkinson Disease
|
Marshall, Thomas
|
|
2017
|
20 |
10 |
p. 1383-1393
|
article
|
| 22 |
PCSK9 Inhibitors Show Value for Patients and the US Health Care System
|
Cheng, Wei-Han
|
|
2017
|
20 |
10 |
p. 1270-1278
|
article
|
| 23 |
Reviewer Acknowledgement 20/10
|
|
|
2017
|
20 |
10 |
p. 1434-1439
|
article
|
| 24 |
Scientific Evidence in Health Technology Assessment Reports: An In-Depth Analysis of European Assessments on High-Risk Medical Devices
|
Olberg, Britta
|
|
2017
|
20 |
10 |
p. 1420-1426
|
article
|
| 25 |
Table of Contents
|
|
|
2017
|
20 |
10 |
p. i-iii
|
article
|
| 26 |
The Role of Noncomparative Evidence in Health Technology Assessment Decisions
|
Griffiths, Elizabeth A.
|
|
2017
|
20 |
10 |
p. 1245-1251
|
article
|
| 27 |
The Use of Decomposition Methods in Real-World Treatment Benefits Evaluation for Patients with Type 2 Diabetes Initiating Different Injectable Therapies: Findings from the INITIATOR Study
|
Brekke, Lee
|
|
2017
|
20 |
10 |
p. 1252-1259
|
article
|
| 28 |
Value of Implementation of Strategies to Increase the Adherence of Health Professionals and Cancer Survivors to Guideline-Based Physical Exercise
|
Mewes, Janne C.
|
|
2017
|
20 |
10 |
p. 1336-1344
|
article
|
| 29 |
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial
|
Hall, Peter S.
|
|
2017
|
20 |
10 |
p. 1311-1318
|
article
|
Journal description